GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (HKSE:00853) » Definitions » Tax Expense

MicroPort Scientific (HKSE:00853) Tax Expense : HK$177 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is MicroPort Scientific Tax Expense?

MicroPort Scientific's tax expense for the months ended in Dec. 2023 was HK$69 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$177 Mil.


MicroPort Scientific Tax Expense Historical Data

The historical data trend for MicroPort Scientific's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific Tax Expense Chart

MicroPort Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 266.91 80.67 108.96 51.36 176.83

MicroPort Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.17 42.65 9.05 107.67 69.48

MicroPort Scientific Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$177 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort Scientific  (HKSE:00853) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


MicroPort Scientific Tax Expense Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort Scientific (HKSE:00853) Business Description

Traded in Other Exchanges
Address
1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.
Executives
Shang Hai Zhang Jiang Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Maxwell Maxcare Science Foundation Limited 2201 Interest of corporation controlled by you
We'tron Capital Limited 2101 Beneficial owner
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hfty I Holdings Pte. Ltd. 2101 Beneficial owner
Otsuka Holdings Co., Ltd.
Otsuka Medical Devices Co., Ltd.
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

MicroPort Scientific (HKSE:00853) Headlines

No Headlines